Search

239 Result(s)

“Rapid progress towards clinical candidates”
The rise of drug-resistant pathogens is a real threat.
Human Health Innovation

“Rapid progress towards clinical candidates”

Michel Pairet, Member of the Board of Managing Directors, explains why Boehringer Ingelheim expands its commitment to fighting drug resistant infections with a new joint venture.
Championing Novel Science
Borderline Personality Disorder

Championing Novel Science

Dr. Vikas Mohan Sharma discusses the unmet need in Borderline Personality Disorder treatment and Boehringer Ingelheim’s role in research
Our position
Patient Centricity

Our position

Boehringer Ingelheim’s position on compassionate use of investigational medications.
EADV: New frontiers in GPP
EADV Virtual
GPP

EADV: New frontiers in GPP

Dr. Emmanuelle Clerisme-Beaty reflects on the latest developments for generalized pustular psoriasis at this year’s virtual EADV congress